ARCA biopharma, Inc. (ABIO)

ARCA biopharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	37.43	42.45	53.36	49.07	8.36
Cash & Cash Equivalents	37.43	42.45	53.36	49.07	8.36
Cash Growth	-11.81%	-20.45%	8.74%	486.76%	26.56%
Other Current Assets	0.16	0.25	1.06	0.9	0.12
Total Current Assets	37.59	42.7	54.42	49.97	8.48
Property, Plant & Equipment	0.26	0.37	0.49	0.45	0.03
Other Long-Term Assets	0.01	0.02	0.02	0.01	0.02
Total Long-Term Assets	0.27	0.39	0.5	0.46	0.06
Total Assets	37.86	43.09	54.92	50.43	8.54
Accounts Payable	0.36	0.33	1.12	1.77	0.42
Other Current Liabilities	0.28	0.8	2.38	1.73	0.51
Total Current Liabilities	0.64	1.13	3.5	3.5	0.93
Long-Term Debt	0.2	0.28	0.38	0.41	0
Total Long-Term Liabilities	0.2	0.28	0.38	0.41	0
Total Liabilities	0.84	1.41	3.88	3.91	0.93
Total Debt	0.2	0.28	0.38	0.41	0
Debt Growth	-27.14%	-26.89%	-6.36%	-	-
Retained Earnings	-188.74	-183.4	-173.48	-154.15	-144.42
Shareholders' Equity	37.02	41.67	51.04	46.52	7.61
Net Cash / Debt	37.23	42.17	52.98	48.66	8.36
Net Cash / Debt Growth	-11.71%	-20.41%	8.87%	481.87%	26.56%
Net Cash Per Share	2.58	2.93	3.81	10.33	6.33
Working Capital	36.96	41.57	50.92	46.47	7.55
Book Value Per Share	2.57	2.89	3.67	9.88	5.76

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).